DEXCOM, INC. (DXCM) Free cash flow 2016–2025
DEXCOM, INC. (DXCM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.1BFY2025 · since FY2016: $500,000 → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +70.8% |
| FY2024 | $630.7M | +23.2% |
| FY2023 | $511.9M | +68.0% |
| FY2022 | $304.7M | +471.7% |
| FY2021 | $53.3M | -80.7% |
| FY2020 | $276.6M | +105.7% |
| FY2019 | $134.5M | +139.8% |
| FY2018 | $56.1M | +115.8% |
| FY2017 | $26.0M | +5100.0% |
| FY2016 | $500,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DXCM financial trends
DXCM RevenueDXCM Net incomeDXCM Net marginDXCM Gross profitDXCM Gross marginDXCM Operating incomeDXCM Operating marginDXCM Operating cash flowDXCM Capital expendituresDXCM Return on equityDXCM Stock buybacksDXCM Dividends paidDXCM Total assetsDXCM Total liabilitiesDXCM Shareholders’ equityDXCM overview →